SG11201907938RA - Pentosan Polysulfate, Pharmaceutical Composition, And Anticoagulant - Google Patents
Pentosan Polysulfate, Pharmaceutical Composition, And AnticoagulantInfo
- Publication number
- SG11201907938RA SG11201907938RA SG11201907938RA SG11201907938RA SG11201907938RA SG 11201907938R A SG11201907938R A SG 11201907938RA SG 11201907938R A SG11201907938R A SG 11201907938RA SG 11201907938R A SG11201907938R A SG 11201907938RA SG 11201907938R A SG11201907938R A SG 11201907938RA
- Authority
- SG
- Singapore
- Prior art keywords
- anticoagulant
- pharmaceutical composition
- pentosan polysulfate
- polysulfate
- pentosan
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229940127219 anticoagulant drug Drugs 0.000 title 1
- 229940043138 pentosan polysulfate Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/14—Hemicellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/14—Hemicellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L97/00—Compositions of lignin-containing materials
- C08L97/02—Lignocellulosic material, e.g. wood, straw or bagasse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Birds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017035916 | 2017-02-28 | ||
JP2017166559A JP6281659B1 (ja) | 2017-02-28 | 2017-08-31 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
PCT/JP2018/007138 WO2018159580A1 (ja) | 2017-02-28 | 2018-02-27 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201907938RA true SG11201907938RA (en) | 2019-09-27 |
Family
ID=61231477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201907938RA SG11201907938RA (en) | 2017-02-28 | 2018-02-27 | Pentosan Polysulfate, Pharmaceutical Composition, And Anticoagulant |
Country Status (15)
Country | Link |
---|---|
US (1) | US11274165B2 (de) |
EP (1) | EP3590971B1 (de) |
JP (1) | JP6281659B1 (de) |
KR (1) | KR102520754B1 (de) |
CN (1) | CN110325553B (de) |
AU (1) | AU2018229054B2 (de) |
BR (1) | BR112019017527B1 (de) |
CA (1) | CA3054533C (de) |
ES (1) | ES2929538T3 (de) |
HU (1) | HUE060518T2 (de) |
MX (1) | MX2019010189A (de) |
PL (1) | PL3590971T3 (de) |
PT (1) | PT3590971T (de) |
SG (1) | SG11201907938RA (de) |
WO (1) | WO2018159580A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6225321B1 (ja) | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
WO2018043666A1 (ja) * | 2016-08-31 | 2018-03-08 | 王子ホールディングス株式会社 | 酸性キシロオリゴ糖の製造方法 |
JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
SG11201911318SA (en) | 2017-05-31 | 2020-01-30 | Oji Holdings Corp | Moisturizing topical preparation |
BR112020004787A2 (pt) | 2017-09-12 | 2020-09-24 | Oji Holdings Corporation | polissulfato de pentosano, composição farmacêutica, anticoagulante, e, método para produzir polissulfato de pentosano |
PL3730521T3 (pl) * | 2017-12-20 | 2023-10-09 | Oji Holdings Corporation | Polisiarczan pentozanu i lek zawierający polisiarczan pentozanu |
WO2020039480A1 (ja) * | 2018-08-20 | 2020-02-27 | 株式会社レクメド | 新規ポリ硫酸ペントサンナトリウム製剤 |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4843100B1 (de) | 1969-09-05 | 1973-12-17 | ||
JPS4843100A (de) * | 1971-09-30 | 1973-06-22 | ||
US4168742A (en) | 1978-03-27 | 1979-09-25 | Hudson Products Corporation | Tube bundle |
FR2538404B1 (de) | 1982-12-28 | 1985-08-23 | Anic Spa | |
FR2543145B1 (fr) | 1983-03-24 | 1986-10-17 | Sanofi Sa | Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante |
JPS60112708A (ja) | 1983-11-24 | 1985-06-19 | Maruho Kk | 皮膚用保湿剤 |
FR2572731B1 (fr) * | 1984-11-07 | 1987-03-06 | Sanofi Sa | Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale |
JPS61130301A (ja) | 1984-11-30 | 1986-06-18 | Tokyo Univ | 抗凝血活性を有する硫酸化キシロフラナン及びその製造法 |
JPS61130302A (ja) | 1984-11-30 | 1986-06-18 | Tokyo Univ | 抗凝血活性を有する硫酸化リボフラナン及びその製造法 |
US5672334A (en) | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
FR2645745B1 (fr) | 1989-04-12 | 1991-09-27 | Anben Ste Civile | Compositions therapeutiques pour le traitement ou la prevention du ronflement |
DE3917982A1 (de) | 1989-06-02 | 1990-12-06 | Behringwerke Ag | Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen |
FR2648463B1 (fr) | 1989-06-14 | 1993-01-22 | Inst Fs Rech Expl Mer | Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention |
JPH0776175B2 (ja) | 1990-04-26 | 1995-08-16 | サイトアーレクス・コーポレーシヨン | 損傷されたかまたは病気になった組織の局所的処置用の組成物および方法 |
US20010005720A1 (en) | 1995-06-07 | 2001-06-28 | U.S.A. As Represented By The Secretary Department Of Health And Human Services | Method of treating chronic progressive vascular scarring diseases |
DE19632840A1 (de) | 1996-08-14 | 1998-02-19 | Landsberger Albert | Vitamin A-haltige Zusammensetzung |
JPH10195107A (ja) | 1997-01-10 | 1998-07-28 | Shiseido Co Ltd | オリゴ硫酸化ヒアルロン酸 |
JP4336905B2 (ja) | 1997-12-19 | 2009-09-30 | マルホ株式会社 | 硫酸化多糖類含有皮膚保湿乳剤性ローション剤 |
US6593310B1 (en) | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
DE10141106A1 (de) | 2001-08-22 | 2003-03-13 | Aventis Pharma Gmbh | Verwendung von Heparinoid-Derivaten zur Behandlung und Diagnose von mit Heparinoiden behandelbaren Erkrankungen |
JP4073661B2 (ja) | 2001-12-20 | 2008-04-09 | 王子製紙株式会社 | 酸性キシロオリゴ糖組成物の製造方法 |
JP3772749B2 (ja) | 2002-01-25 | 2006-05-10 | 王子製紙株式会社 | メラニン生成抑制剤 |
JP2003221339A (ja) | 2002-01-29 | 2003-08-05 | Oji Paper Co Ltd | 抗炎症剤 |
ITMI20031618A1 (it) | 2003-08-06 | 2005-02-07 | Inalco Spa | Derivati polisaccaridici dotati di alta attivita' |
RU2347574C2 (ru) | 2004-05-27 | 2009-02-27 | Эвиджен, Инк. | Способы лечения коагулопатий с использованием сульфатированных полисахаридов |
SI1778709T1 (sl) | 2004-08-05 | 2008-12-31 | Ivax Drug Res Inst Ltd | Polisulfatirani glikozidi in njihove soli |
US20060194759A1 (en) | 2005-02-25 | 2006-08-31 | Eidelson Stewart G | Topical compositions and methods for treating pain and inflammation |
US20080214480A1 (en) | 2005-07-22 | 2008-09-04 | Trf Pharma, Inc. | Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae |
WO2007123800A2 (en) | 2006-04-03 | 2007-11-01 | Nutramax Laboratories, Inc. | Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
GB0610350D0 (en) | 2006-05-25 | 2006-07-05 | Univ Liverpool | prevention and/or treatment of neuodegenerative disorders |
JPWO2008066193A1 (ja) | 2006-11-27 | 2010-03-11 | チッソ株式会社 | 化粧料組成物 |
WO2008107906A1 (en) | 2007-03-06 | 2008-09-12 | Alembic Limited | Process for the preparation of pentosan polysulfate or salts thereof |
FI121811B (fi) * | 2007-06-01 | 2011-04-29 | Upm Kymmene Corp | Uudet dispersiot ja menetelmä niiden valmistamiseksi |
HUP0900072A2 (hu) | 2009-02-06 | 2010-09-28 | Egis Gyogyszergyar Nyilvanosan | Transzdermális gyógyszerkészítmények |
WO2009087581A1 (en) | 2008-01-04 | 2009-07-16 | Alembic Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
JP2009196915A (ja) | 2008-02-20 | 2009-09-03 | Ezaki Glico Co Ltd | 化粧品用組成物 |
AU2008100730B4 (en) | 2008-07-04 | 2008-10-02 | Parnell Technologies Pty Ltd | Sulfated polysaccharide compound for clinical use and the preparation thereof |
FR2935386B1 (fr) | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
RU2519781C2 (ru) | 2009-02-02 | 2014-06-20 | Оцука Кемикал Ко., Лтд. | Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство |
CN102061323B (zh) | 2010-11-10 | 2013-09-25 | 山东龙力生物科技股份有限公司 | 一种植物木质纤维素的综合利用工艺 |
WO2012101544A1 (en) | 2011-01-29 | 2012-08-02 | Alembic Pharmaceuticals Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
WO2012114349A1 (en) | 2011-02-23 | 2012-08-30 | Cadila Healthcare Limited | An improved process for the preparation of pentosan polysulfate sodium |
CN102766225B (zh) * | 2011-05-06 | 2015-08-05 | 上海医药工业研究院 | 一种戊聚糖聚硫酸钠的制备方法以及一种寡聚木糖 |
WO2013186857A1 (ja) | 2012-06-12 | 2013-12-19 | 株式会社リボミック | Fgf2に対するアプタマー及びその使用 |
ITMI20130112A1 (it) | 2013-01-24 | 2014-07-25 | Chemi Spa | Metodo di qualificazione di preparazioni di pentosan polifosfato, sue materie prime e processi di produzione |
JO3529B1 (ar) | 2013-02-08 | 2020-07-05 | Amgen Res Munich Gmbh | مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد |
JP6132302B2 (ja) | 2013-05-28 | 2017-05-24 | リーディアント・バイオサイエンシーズ・ソシエタ・アノニマLeadiant Biosciences S.A. | 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体 |
CN103320548A (zh) | 2013-06-24 | 2013-09-25 | 稼禾生物股份有限公司 | 一种利用农作物秸秆制备低聚木糖和纤维素的方法 |
JP6403317B2 (ja) | 2013-07-19 | 2018-10-10 | 学校法人慶應義塾 | 抗腫瘍剤 |
PT3298047T (pt) * | 2015-05-20 | 2022-03-02 | Chemi Spa | Processo para a preparação de polissacáridos |
US20180318336A1 (en) | 2015-05-27 | 2018-11-08 | Vanguard Therapeutics, Inc. | Pentosan polysulfate sodium for the treatment of sickle cell disease |
CN106832020A (zh) | 2015-12-04 | 2017-06-13 | 长春工业大学 | 一种玉米秸秆戊聚糖硫酸酯的制备工艺 |
CN105907896B (zh) | 2016-05-16 | 2019-11-12 | 中国科学院广州能源研究所 | 一种利用木质纤维原料联产高浓度木糖和低聚木糖的方法 |
JP6225321B1 (ja) | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
WO2018043666A1 (ja) | 2016-08-31 | 2018-03-08 | 王子ホールディングス株式会社 | 酸性キシロオリゴ糖の製造方法 |
JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
-
2017
- 2017-08-31 JP JP2017166559A patent/JP6281659B1/ja active Active
-
2018
- 2018-02-27 PL PL18761900.2T patent/PL3590971T3/pl unknown
- 2018-02-27 PT PT187619002T patent/PT3590971T/pt unknown
- 2018-02-27 CA CA3054533A patent/CA3054533C/en active Active
- 2018-02-27 AU AU2018229054A patent/AU2018229054B2/en active Active
- 2018-02-27 KR KR1020197024908A patent/KR102520754B1/ko active IP Right Grant
- 2018-02-27 HU HUE18761900A patent/HUE060518T2/hu unknown
- 2018-02-27 CN CN201880013926.0A patent/CN110325553B/zh active Active
- 2018-02-27 BR BR112019017527-0A patent/BR112019017527B1/pt active IP Right Grant
- 2018-02-27 US US16/489,074 patent/US11274165B2/en active Active
- 2018-02-27 SG SG11201907938RA patent/SG11201907938RA/en unknown
- 2018-02-27 ES ES18761900T patent/ES2929538T3/es active Active
- 2018-02-27 WO PCT/JP2018/007138 patent/WO2018159580A1/ja unknown
- 2018-02-27 MX MX2019010189A patent/MX2019010189A/es unknown
- 2018-02-27 EP EP18761900.2A patent/EP3590971B1/de active Active
Also Published As
Publication number | Publication date |
---|---|
AU2018229054A1 (en) | 2019-09-12 |
CA3054533A1 (en) | 2018-09-07 |
PT3590971T (pt) | 2022-11-29 |
MX2019010189A (es) | 2019-10-09 |
KR102520754B1 (ko) | 2023-04-11 |
US11274165B2 (en) | 2022-03-15 |
HUE060518T2 (hu) | 2023-03-28 |
CA3054533C (en) | 2024-05-28 |
CN110325553B (zh) | 2021-10-08 |
EP3590971B1 (de) | 2022-10-12 |
JP2018141120A (ja) | 2018-09-13 |
US20200062867A1 (en) | 2020-02-27 |
KR20190120216A (ko) | 2019-10-23 |
JP6281659B1 (ja) | 2018-02-21 |
EP3590971A4 (de) | 2020-12-09 |
BR112019017527B1 (pt) | 2024-03-12 |
AU2018229054B2 (en) | 2021-09-16 |
CN110325553A (zh) | 2019-10-11 |
EP3590971A1 (de) | 2020-01-08 |
WO2018159580A1 (ja) | 2018-09-07 |
BR112019017527A2 (pt) | 2020-03-31 |
ES2929538T3 (es) | 2022-11-30 |
PL3590971T3 (pl) | 2023-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201907938RA (en) | Pentosan Polysulfate, Pharmaceutical Composition, And Anticoagulant | |
PH12020500396A1 (en) | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof | |
PH12019502058A1 (en) | Farnesoid x receptor agonists and uses thereof | |
MX2019009839A (es) | Celulas eritroides funcionalizadas. | |
MX2018015699A (es) | Formulaciones de cannabinoide. | |
PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
PH12017501342A1 (en) | Glycan therapeutics and related methods thereof | |
MX2019000427A (es) | Formas de dosificacion oral de cannabinoide de alta concentracion. | |
GEP20207158B (en) | Amide-substituted pyridinyltriazole derivatives and uses thereof | |
MX2018006217A (es) | Agonistas del receptor de apelina y metodos de uso. | |
MY191581A (en) | Anti-pd-1 antibodies | |
MY187047A (en) | Selective pyy compounds and uses thereof | |
AU2017228405A8 (en) | Small molecule IRE1-alpha inhibitors | |
SA518400356B1 (ar) | مثبطات الأرجيناز واستخداماتها العلاجية | |
PH12019502676A1 (en) | Moisturizing topical preparation | |
PH12020551716A1 (en) | Anti-ror antibody constructs | |
MX2019001121A (es) | Nuevas formulaciones y composiciones de cannabis en comprimidos y metodos para su elaboracion. | |
MX2018012618A (es) | Composiciones farmaceuticas orales de mesalazina. | |
MX2020012800A (es) | Cannabinoides y usos de los mismos. | |
MX2020011756A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
BR112022000855A2 (pt) | Moduladores de nlrp3 | |
PH12018501758A1 (en) | Oritavancin formulations | |
BR112021014566A2 (pt) | Moduladores de gpr35 | |
TW201613861A (en) | Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC | |
EA202091403A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола |